Bursky Annual Symposium: James Allison (University of Texas/MD Anderson Cancer Center) – “Immune Checkpoint Blockade in Cancer Therapy: Historical Perspective, New Insights, and Prospects for Cures”

March 7, 2019
8:30 am - 12:30 pm
Eric P. Newman Education Center (EPNEC) Auditorium (Medical Campus)

“Immune Checkpoint Blockade in Cancer Therapy: Historical Perspective, New Insights, and Prospects for Cures”


Hosted by the Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs), the symposium features distinguished scientists and profile remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors.

8:30 to 8:35         Welcome by Robert Schreiber, Ph.D.

8:35 to 8:45         Comments by Mr. Andrew M. Bursky

8:45 to 8:55         Comments by Dean David H. Perlmutter, M.D., with introduction of new Chancellor

8:55 to 9:05         Comments by Chancellor Elect Andrew D. Martin

9:05 to 10:05       James P. Allison, Ph.D., Keynote Speaker:“Immune Checkpoint Blockade in Cancer Therapy: Historical Perspective, New Insights, and Prospects for Cures”

10:05 to 10:50    Marco Colonna, M.D. (WashU Pathology & Immunology):  “ILC Recognition of Tumor Cells”

10:50 to 11:35    Shabaana Khader, Ph.D. (WashU Molecular Microbiology): “Human Tuberculosis: A moving target”

11:35 to 12:20    John P. Atkinson, M.D. (WashU Medicine, Rheumatology): “Genetic Variants in Complement Regulators Causing Human Disease”

12:45 to 1:45       Lunch for invited guests in the Great Room (EPNEC)

** Keynote speaker will speak for 50 minutes followed by 10 minutes of Q&A;
Invited speakers will speak for 40 mins. each followed by 5 minutes for Q&A.

For inquiries contact Amy Johnson.